NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

PM, I suspect even after UK approvals everyone will be complaining when share price is still languishing well under a dollar. I am not sure if anything will change until they bring a big pharma partner.

If the SP managed to climb to $1.80 before any TLD, JA, or MIA, it will manage to surpass that SP after MHRA approval. By that time, GBM patients in the UK and elsewhere (and even in the USA) will know that a treatment that can add years to their life, does exist.

NWBO has a treatment that in the near future can add years to GBM patients and will be able to some lives. DCVax-L is not a revolutionary, far superior toothpaste that would still require years of advertising. I am also confident that NWBO knows whether or not as well as when at the post MHRA approval period, they have to engage a big pharma partner.